Rachel Schreiber, MD
Allergy & Immunology · Rockville, MDNPI 1326191198
Payments from drug & device makers
Across 755 payments — averaging $183.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron$85K
- AstraZeneca$15K
- Genentech USA, Inc.$8K
- Novartis$7K
- GSK$7K
- Sanofi$5K
- plus $11K from 28 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron | 197 | $85,091 |
| AstraZeneca | 100 | $14,577 |
| Genentech USA, Inc. | 32 | $8,198 |
| Novartis | 44 | $7,443 |
| GSK | 79 | $7,251 |
| Sanofi | 35 | $4,958 |
| Amgen(2 entities) | 32 | $3,465 |
| Regeneron Healthcare Solutions, Inc. | 54 | $2,963 |
| Takeda Pharmaceuticals U.S.A., Inc. | 31 | $829 |
| Grifols USA, LLC | 21 | $511 |
| Kaleo, Inc. | 18 | $470 |
| Pfizer | 18 | $350 |
| Optinose US, Inc. | 9 | $343 |
| Incyte Corporation | 13 | $334 |
| Alk-abello, Inc | 10 | $235 |
| ARS Pharmaceuticals Operations, Inc. | 9 | $229 |
| Biocryst US Sales Co., LLC | 9 | $212 |
| CSL Behring | 8 | $198 |
| Pharming Healthcare, Inc. | 8 | $194 |
| Phadia US Inc. | 6 | $121 |
| Aquestive Therapeutics, Inc. | 1 | $119 |
| AbbVie | 3 | $58 |
| Ionis Pharmaceuticals, Inc. | 2 | $55 |
| LEO Pharma Inc. | 2 | $48 |
| Lilly USA, LLC | 2 | $43 |
| Galderma Laboratories, L.p. | 2 | $38 |
| Boehringer Ingelheim | 2 | $36 |
| Hikma Pharmaceuticals USA | 2 | $33 |
| Aimmune Therapeutics, Inc. | 1 | $27 |
| ADMA Biomanufacturing LLC | 1 | $22 |
| Sanofi-aventis U.S. LLC | 1 | $21 |
| Arcutis Biotherapeutics, Inc. | 1 | $18 |
| Covis Pharma GmbH | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $11 |
How this compares
$138,519 in reported general payments places this provider in the 90th percentile of 105 allergy & immunology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other allergy & immunology in Rockville
- Sudhir SekhsariaRockville$565K
- Kristin SokolRockville$62K
- Julia SohnRockville$16K
- Nneoma ObiejembaRockville$11K
- Paul KeiserRockville$7K
- Jordana GoldmanRockville$6K
- Gina Dapul-HidalgoRockville$5K
- Ryan BolotteRockville$4K
- Mark ScarupaWheaton$1.2M
- Antoine AzarBaltimore$990K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.